Clinical findings in patients with marker chromosomes identified by fluorescence in situ hybridization

Rina Plattner(University of Kentucky), CatherineG. Palmer(Indiana University School of Medicine), JudithH. Miles(University of Missouri), NylaA. Heerema(Indiana University School of Medicine), Shirley Soukup(Cincinnati Children's Hospital Medical Center), PatriciaN. Howard-Peebles(Genetics and IVF Institute)
Human Genetics
July 1, 1993
10.1007/bf00205086
Cited by 76

Related Papers

c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF
|Genes & Development|1999|426
Activation of Abl Tyrosine Kinases Promotes Invasion of Aggressive Breast Cancer Cells
|Cancer Research|2006|199
Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
|PLoS ONE|2013|133
Molecular cytogenetic analysis of inv dup(15) chromosomes, using probes specific for the Prader-Willi/Angelman syndrome region: clinical implications.
|PubMed|1994|129
Abl tyrosine kinases are required for infection by Shigella flexneri
|The EMBO Journal|2003|125